Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis
Open Access
- 30 April 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (4) , e0250944
Abstract
Introduction: Stroke is a common complication in children with tuberculous meningitis (TBM). Host proteins may give us insight into the mechanisms of stroke in TBM and serve as biomarkers for detection of stroke, however, they have not been widely explored. In this study, we compared the concentrations of cerebrospinal fluid (CSF) and serum proteins between children who had TBM-related stroke and children with TBM without stroke. Methods: We collected CSF and serum from 47 children consecutively admitted to the Tygerberg Academic Hospital in Cape Town, South Africa between November 2016, and November 2017, on suspicion of having TBM. A multiplex platform was used to measure the concentrations of 69 host proteins in CSF and serum from all study participants. Results: After classification of study participants, 23 (48.9%) out of the 47 study participants were diagnosed with TBM, of which 14 (60.9%) demonstrated radiological arterial ischemic infarction. The levels of lipocalin-2, sRAGE, IP-10/ CXCL10, sVCAM-1, MMP-1, and PDGF-AA in CSF samples and the levels of D-dimer, ADAMTS13, SAA, ferritin, MCP-1/ CCL2, GDF-15 and IL-13 in serum samples were statistically different between children who had TBM-related stroke and children with TBM without stroke. After correcting for multiple testing, only the levels of sVCAM-1, MMP-1, sRAGE, and IP-10/ CXCL10 in CSF were statistically different between the two groups. CSF and serum protein biosignatures indicated stroke in children diagnosed with TBM with up to 100% sensitivity and 88.9% specificity. Conclusion: Serum and CSF proteins may serve as biomarkers for identifying individuals with stroke amongst children diagnosed with TBM at admission and may guide us to understand the biology of stroke in TBM. This was a pilot study, and thus further investigations in larger studies are needed.Keywords
Funding Information
- South African Government through the Technology Innovation Agency (TIA)
- South African Research Chairs Initiative (SARChi) in TB Biomarkers (86535)
- International Collaborations in Infectious Disease Research (5U01IA115619)
- National Research Foundation (109437)
- European and Developing Countries Clinical Trials Partnership (TMA2018SF-2470-TBMBIOMARKERS)
- South African Medical Research Council (57020)
This publication has 33 references indexed in Scilit:
- D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding DisordersSeminars in Thrombosis and Hemostasis, 2012
- Stroke angiogenesis and phytochemicalsFrontiers in Bioscience-Scholar, 2012
- A study of cytokines in tuberculous meningitis: Clinical and MRI correlationNeuroscience Letters, 2010
- von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental strokeBlood, 2009
- Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitisEuropean Journal of Paediatric Neurology, 2009
- Vascular MMP-9/TIMP-2 and Neuronal MMP-10 Up-Regulation in Human Brain after Stroke: A Combined Laser Microdissection and Protein Array StudyJournal of Proteome Research, 2009
- MRI to demonstrate diagnostic features and complications of TBM not seen with CTChild's Nervous System, 2008
- Proinflammatory cytokine levels in the serum and cerebrospinal fluid of tuberculous meningitis patientsNeuroscience Letters, 2008
- Central Nervous System Tuberculosis: Pathogenesis and Clinical AspectsClinical Microbiology Reviews, 2008
- Interleukin-8 levels in children with bacterial, tuberculous and aseptic meningitisIndian Journal of Pediatrics, 2002